Pre-Operative, Single-Dose Ipilimumab and/or Cryoablation in Early Stage/Resectable Breast Cancer

Clinical trial NCT01502592 · COMPLETED

Trial details

NCT number: NCT01502592
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Invasive Adenocarcinoma of the Breast

Start date: 2011-12-01
Primary completion: 2014-12-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.